186 related articles for article (PubMed ID: 37461300)
1. Truncated TDP-43 proteoforms diagnostic of frontotemporal dementia with TDP-43 pathology.
Forgrave LM; Moon KM; Hamden JE; Li Y; Lu P; Foster LJ; Mackenzie IRA; DeMarco ML
Alzheimers Dement; 2024 Jan; 20(1):103-111. PubMed ID: 37461300
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing post-translational modifications in dominantly inherited frontotemporal dementias: FTLD-TDP Type A (GRN) vs Type B (C9orf72).
Cracco L; Doud EH; Hallinan GI; Garringer HJ; Jacobsen MH; Richardson RM; Buratti E; Vidal R; Ghetti B; Newell KL
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12836. PubMed ID: 35836354
[TBL] [Abstract][Full Text] [Related]
3. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
Carlos AF; Josephs KA
J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398
[TBL] [Abstract][Full Text] [Related]
4. Plasma proteome profiling identifies changes associated to AD but not to FTD.
Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE
Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219
[TBL] [Abstract][Full Text] [Related]
5. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
[TBL] [Abstract][Full Text] [Related]
6. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
[TBL] [Abstract][Full Text] [Related]
7. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.
Neumann M; Lee EB; Mackenzie IR
Adv Exp Med Biol; 2021; 1281():201-217. PubMed ID: 33433877
[TBL] [Abstract][Full Text] [Related]
8. Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia.
Fontana E; Bongianni M; Benussi A; Bronzato E; Scialo C; Sacchetto L; Cagnin A; Castriciano S; Buratti E; Gardoni F; Italia M; Schreiber A; Ferracin C; Fiorini M; Newell KL; Cracco L; Garringer HJ; Cecchini MP; Polymenidou M; Padovani A; Monaco S; Legname G; Ghetti B; Borroni B; Zanusso G
Alzheimers Dement; 2024 Feb; 20(2):1156-1165. PubMed ID: 37908186
[TBL] [Abstract][Full Text] [Related]
9. Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.
Pickles S; Gendron TF; Koike Y; Yue M; Song Y; Kachergus JM; Shi J; DeTure M; Thompson EA; Oskarsson B; Graff-Radford NR; Boeve BF; Petersen RC; Wszolek ZK; Josephs KA; Dickson DW; Petrucelli L; Cook CN; Prudencio M
Acta Neuropathol Commun; 2022 Jul; 10(1):107. PubMed ID: 35879741
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
11. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.
Hu WT; Watts K; Grossman M; Glass J; Lah JJ; Hales C; Shelnutt M; Van Deerlin V; Trojanowski JQ; Levey AI
Neurology; 2013 Nov; 81(22):1945-52. PubMed ID: 24174584
[TBL] [Abstract][Full Text] [Related]
12. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ
JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
[TBL] [Abstract][Full Text] [Related]
16. Combined Pathologies in FTLD-TDP Types A and C.
Gefen T; Ahmadian SS; Mao Q; Kim G; Seckin M; Bonakdarpour B; Ramos EM; Coppola G; Rademakers R; Rogalski E; Rademaker A; Weintraub S; Mesulam MM; Geula C; Bigio EH
J Neuropathol Exp Neurol; 2018 May; 77(5):405-412. PubMed ID: 29584904
[TBL] [Abstract][Full Text] [Related]
17. Novel CSF biomarkers for frontotemporal lobar degenerations.
Hu WT; Chen-Plotkin A; Grossman M; Arnold SE; Clark CM; Shaw LM; McCluskey L; Elman L; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
Neurology; 2010 Dec; 75(23):2079-86. PubMed ID: 21048198
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
19. Psychotic symptoms in frontotemporal dementia with TDP-43 tend to be associated with type B pathology.
Hirsch-Reinshagen V; Hercher C; Vila-Rodriguez F; Neumann M; Rademakers R; Honer WG; Hsiung GR; Mackenzie IR
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12921. PubMed ID: 37386798
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
Mol MO; Miedema SSM; van Swieten JC; van Rooij JGJ; Dopper EGP
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
